Routine Collection of High-Resolution cryo-EM Datasets Using 200 KV Transmission Electron Microscope
March 16th, 2022
6.1K views
High-resolution cryo-EM maps of macromolecules can be also achieved by using 200 kV TEM microscopes. This protocol shows the best practices for setting accurate optics alignments, data acquisition schemes, and selection of imaging areas that are all essential for the successful collection of high-resolution datasets using a 200 kV TEM.
Overview
This protocol outlines best practices for obtaining high-resolution cryo-EM datasets using 200 kV TEM microscopes. It emphasizes accurate optics alignments, data acquisition schemes, and imaging area selection.
Key Study Components
Area of Science
- Cryo-Electron Microscopy
- Structural Biology
Background
- Cryo-EM is a standard technique for protein structure determination.
- It allows for the study of proteins in near-native conditions.
- This method can capture multiple conformational and functional states simultaneously.
- Recent advancements have made operating Cryo-TEMs easier.
Purpose of Study
- To demonstrate the critical steps in obtaining high-resolution Cryo-EM data.
- To provide a protocol for using standard samples like apoferritin and proteasome.
- To facilitate structure-based drug design through detailed structural information.
Methods Used
- Use of auto grids and liquid nitrogen conditions for sample preparation.
- Automated collection of atlases from selected grids.
- Manual selection of grid squares for data collection.
- Utilization of advanced automation features for efficient data acquisition.
Main Results
- Successful acquisition of high-resolution datasets from 200 kV TEM microscopes.
- Identification of optimal grid squares for imaging.
- Demonstration of automated and manual data collection techniques.
- Establishment of a reliable protocol for future studies.
Conclusions
- The protocol provides a comprehensive guide for obtaining high-resolution Cryo-EM data.
- Training with experienced users is recommended for beginners.
- Advancements in automation enhance the efficiency of Cryo-EM operations.
Frequently Asked Questions
What is Cryo-EM?
Cryo-EM is a technique used to determine the structures of proteins and complexes at high resolution while preserving their native state.
Why use a 200 kV TEM microscope?
200 kV TEM microscopes provide sufficient resolution for high-quality cryo-EM data while being more accessible than higher voltage systems.
What are the key steps in the protocol?
Key steps include sample preparation, grid selection, automated data collection, and image acquisition.
How does Cryo-EM compare to other structural techniques?
Cryo-EM can capture multiple conformational states simultaneously, which is often challenging for other methods.
Is training necessary for using Cryo-TEM?
Yes, it is advisable to have training with experienced users, especially for first-time operators.
What types of samples are used in this protocol?
Standard samples such as apoferritin and proteasome are used to demonstrate the protocol.
Executive Industry Relevance
High-resolution cryo-EM using 200 kV TEM systems enables routine atomic-level protein structure determination, expanding access beyond specialized 300 kV platforms. Automation and real-time quality assessment streamline data acquisition, supporting rapid, reproducible generation of structural insights for early-stage drug discovery. This capability strengthens predictive confidence at the target validation and lead identification inflection points across biopharma portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables elucidation of molecular mechanisms underlying protein function and disease relevance.
- Supports structure-based drug design by providing atomic-resolution maps for target interrogation.
- Facilitates functional target validation through direct visualization of conformational and binding states.
- Reduces reliance on crystallization, broadening the range of tractable targets.
Screening & Assay Development
- Delivers validated structural templates for downstream screening and assay development workflows.
- Standardizes imaging parameters and data quality, ensuring reproducibility across experiments.
- Enables quantitative assessment of ligand binding and conformational changes.
- Supports scalable, automated data collection for high-throughput structural screening.
Translational & Preclinical Research
- Aligns structural outputs with disease-relevant models for translational biomarker development.
- Provides continuity from discovery through preclinical validation by enabling mechanistic de-risking.
- Improves risk-adjusted advancement decisions by clarifying structure-function relationships.
Pipeline & Workflow Integration
This protocol positions 200 kV cryo-EM as a core capability from early discovery through preclinical research, bridging target validation, lead identification, and mechanistic de-risking.
- Discovery Biology: Supports hypothesis testing and pathway clarification by resolving protein structures in near-native states.
- Screening: Provides reproducible, quantitative structural data for compound evaluation and assay readiness.
- Analytics: Enables high-resolution measurements and statistical comparison of structural conditions and ligand interactions.
- Translational Research: Connects atomic-level insights to disease models and biomarker strategies.
- Enterprise Reuse: Establishes a standardized, automated workflow adaptable across diverse protein targets and research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and throughput via automation and real-time quality control.
- Strategic Value: Enables more informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of structurally validated targets.
Implementation Considerations
- Requires expertise in cryo-EM operation and data interpretation, with initial training recommended.
- Needs access to 200 kV TEM systems equipped with energy filters and direct electron detectors.
- Demands robust data management and quality assessment infrastructure for high-throughput workflows.
- Standardization of imaging parameters and automation protocols is critical for cross-team reproducibility.
- Adaptation to specific protein targets may require optimization of sample preparation and imaging conditions.
Biopharma FAQs
Why does null hypothesis testing matter for cryo-EM target validation?
Null hypothesis testing in cryo-EM structural analysis enables objective assessment of whether observed conformational or binding changes are statistically significant, supporting robust target validation decisions. This reduces the risk of advancing targets based on ambiguous or artifactual structural data. Reliable statistical thresholds help ensure only biologically meaningful findings inform portfolio progression.
How does independent variable isolation fit cryo-EM data acquisition?
Isolating variables such as ice thickness, grid quality, and imaging parameters during cryo-EM data acquisition ensures that structural differences reflect true biological effects rather than technical artifacts. This approach strengthens the interpretability of structural outputs and supports reproducible discovery-stage workflows. Controlled acquisition variables are essential for cross-study comparability.
What do quantitative dependent variable measurements enable in cryo-EM?
Quantitative measurements of resolution, contrast, and particle homogeneity in cryo-EM datasets enable precise evaluation of structural quality and suitability for atomic model building. These outputs inform go/no-go decisions for downstream drug design and mechanistic studies. High-quality quantitative metrics support confident advancement of structurally validated targets.
Why are replication requirements critical for cross-functional cryo-EM teams?
Replication of cryo-EM data collection and analysis across different operators and sessions ensures that structural findings are robust and not operator-dependent. This is vital for cross-functional collaboration, enabling teams to trust and build upon each other's results. Standardized protocols and automation features facilitate reproducible outcomes across enterprise R&D groups.
What statistical analysis capabilities are needed before cryo-EM implementation?
Robust statistical analysis tools are required to assess resolution, map quality, and particle distribution in cryo-EM datasets prior to implementation in drug discovery pipelines. These capabilities support objective evaluation of data suitability for atomic modeling and downstream applications. Integrating statistical quality control ensures only high-confidence structures inform R&D decisions.
Chapters in this video
0:04
Introduction
1:27
Grid Loading, Mapping, and Selection of Best Cryo-EM Grids for Data Collection
2:36
Setting up a Data Collection Session in the Single Particle Analysis Software
5:44
Final Microscope Alignments Before Starting Data Collection
7:15
Results: Gallery of Grids, Cryo-EM Reconstruction of Apo-Ferritin, and Effect of Energy Filtering on Cryo-EM Images
8:56
Conclusion
